-
EP1147181
European procedure
Extract from the Register of European Patents
EP About this file: EP1147181
| EP1147181 - REPLICATIVE VIRUS DRIVEN BY THE PROMOTER FOR TELOMERASE REVERSE TRANSCRIPTASE FOR USE IN TREATING CANCER [Right-click to bookmark this link] | |||
| Former [2001/43] | TELOMERASE REVERSE TRANSCRIPTASE TRANSCRIPTIONAL REGULATORY SEQUENCES | ||
| [2004/20] | Status | No opposition filed within time limit Status updated on 18.03.2005 Database last updated on 03.09.2024 | Most recent event Tooltip | 14.12.2007 | Lapse of the patent in a contracting state New state(s): PT | published on 16.01.2008 [2008/03] | Applicant(s) | For all designated states GERON CORPORATION 230 Constitution Drive Menlo Park, CA 94025 / US | [N/P] |
| Former [2004/20] | For all designated states Geron Corporation 230 Constitution Drive Menlo Park, CA 94025 / US | ||
| Former [2001/43] | For all designated states Geron Corporation 230 Constitution Drive Menlo Park, CA 94025 / US | Inventor(s) | 01 /
MORIN, Gregg, B. Marina Circle, 622 Davis - 95616 CA / US | 02 /
LICHTSTEINER, Serge Honeysuckle Court,1617 Encinitas - 92024/CA / US | 03 /
VASSEROT, Alain Park Hills Road, 1158 Berkeley - 94708 - CA / US | 04 /
ADAMS, Robert Hillway Drive, 419 Redwood City - 94062 CA / US | 05 /
CARDOZA, Lisa, M. 1600, EAST 3rd Avenue, 2603 San Mateo - 94401/CA / US | 06 /
LEBKOWSKI, Jane, S. Gabarda Way, 150 Portola Valley - 94028 CA / US | [2001/43] | Representative(s) | Bassil, Nicholas Charles, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [N/P] |
| Former [2001/43] | Bassil, Nicholas Charles, et al Kilburn & Strode 20 Red Lion Street London WC1R 4PJ / GB | Application number, filing date | 00917613.2 | 04.02.2000 | [2001/43] | WO2000US03104 | Priority number, date | US19990244438 | 04.02.1999 Original published format: US 244438 | [2001/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0046355 | Date: | 10.08.2000 | Language: | EN | [2000/32] | Type: | A2 Application without search report | No.: | EP1147181 | Date: | 24.10.2001 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.08.2000 takes the place of the publication of the European patent application. | [2001/43] | Type: | B1 Patent specification | No.: | EP1147181 | Date: | 12.05.2004 | Language: | EN | [2004/20] | Search report(s) | International search report - published on: | EP | 30.11.2000 | Classification | IPC: | C12N7/01, C12N15/54, C12N9/12, C12Q1/70, C12N5/10, C12N15/85, A61K35/76, A61P35/00, // (A61K31/7088, 48:00) | [2001/43] | CPC: |
C12N9/1276 (EP);
A61K31/522 (EP);
A61K35/761 (EP);
A61K38/45 (EP);
A61P35/00 (EP);
C12N15/86 (EP);
C12N7/00 (EP);
C12N2710/10332 (EP);
C12N2710/10343 (EP);
| C-Set: |
A61K31/522, A61K2300/00 (EP);
A61K35/761, A61K2300/00 (EP);
A61K38/45, A61K2300/00 (EP)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/43] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | REPLIKATIVER VIRUS GESTEUERT VON DEM PROMOTOR DER REVERSEN TELOMERASE TRANSKRIPTASE ZUR BEHANDLUNG VON KREBS | [2004/20] | English: | REPLICATIVE VIRUS DRIVEN BY THE PROMOTER FOR TELOMERASE REVERSE TRANSCRIPTASE FOR USE IN TREATING CANCER | [2004/20] | French: | VIRUS REPLICATIF CONTROLE PAR LE PROMOTEUR DE LA TRANSCIPTASE INVERSE TELOMEREUSE POUR LE TRAITEMENT DU CANCER | [2004/20] |
| Former [2001/43] | TRANSKRIPTIONSREGULIERENDE SEQUENZEN ZUR TELOMERASE REVERSEN TRANSKRIPTION | ||
| Former [2001/43] | TELOMERASE REVERSE TRANSCRIPTASE TRANSCRIPTIONAL REGULATORY SEQUENCES | ||
| Former [2001/43] | SEQUENCES DE REGULATION TRANSCRIPTIONNELLE DE LA TRANSCRIPTASE INVERSE DE LA TELOMERASE | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 13.06.2001 | National basic fee paid | 13.06.2001 | Designation fee(s) paid | 13.06.2001 | Examination fee paid | Examination procedure | 04.09.2000 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 05.06.2001 | Request for accelerated examination filed | 06.06.2001 | Amendment by applicant (claims and/or description) | 13.06.2001 | Examination requested [2001/43] | 26.10.2001 | Despatch of a communication from the examining division (Time limit: M04) | 26.10.2001 | Decision about request for accelerated examination - accepted: Yes | 04.03.2002 | Reply to a communication from the examining division | 10.06.2002 | Despatch of a communication from the examining division (Time limit: M04) | 21.10.2002 | Reply to a communication from the examining division | 06.12.2002 | Despatch of a communication from the examining division (Time limit: M06) | 04.06.2003 | Reply to a communication from the examining division | 20.08.2003 | Communication of intention to grant the patent | 17.12.2003 | Fee for grant paid | 17.12.2003 | Fee for publishing/printing paid | Opposition(s) | 15.02.2005 | No opposition filed within time limit [2005/18] | Fees paid | Renewal fee | 13.02.2002 | Renewal fee patent year 03 | 12.02.2003 | Renewal fee patent year 04 | 12.02.2004 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | FI | 12.05.2004 | GR | 12.08.2004 | PT | 12.10.2004 | CY | 04.02.2005 | [2008/03] |
| Former [2007/20] | FI | 12.05.2004 | |
| GR | 12.08.2004 | ||
| CY | 04.02.2005 | ||
| Former [2005/06] | FI | 12.05.2004 | |
| GR | 12.08.2004 | ||
| Former [2005/02] | FI | 12.05.2004 | Cited in | International search | [A]US5728379 (MARTUZA ROBERT L [US], et al) [A] 1-10,15,23-26* the whole document *; | [XD]GB2317891 (GERON CORP [US], et al) [XD] 11-14,16-18,20-22 * figure 21 * * page 12, line 23 - line 27 * * page 27, line 14 - line 22 * * page 34, line 5 - line 9 * * page 87, line 6 - line 9 * * page 99, line 7 - line 21 * * example 14 *; | [PX]WO9933998 (BAYER AG [DE], et al) [PX] 11-14,16-18,20-22 * seq ID 3;; figure 10; claims 1-5 * * page 5, line 8 - page 11, line 16 *; | [X] - TAKAKURA ET AL, "Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells", CANCER RESEARCH,US,AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, (19990201), vol. 59, no. 3, ISSN 0008-5472, pages 551 - 557, XP002105209 [X] 11-14,16-18,20-22 * figure 1 * * figure 3 * * figure 4 * * abstract * | [XP] - CONG ET AL, "The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter", HUMAN MOLECULAR GENETICS,GB,OXFORD UNIVERSITY PRESS, SURREY, (1999), vol. 8, no. 1, ISSN 0964-6906, pages 137 - 142, XP002105208 [XP] 11-14 * figure 4 * DOI: http://dx.doi.org/10.1093/hmg/8.1.137 |